InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

BioNTech SE

BNTX Clue Score37
Germany Fiscal year ends December CIK 0001776985
$96.96 +5.32% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $96.96 −60.10% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 10 Oct 2019. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2017Revenue0.06Operating income−0.06Net income−0.09Fiscal year 2018Revenue0.13 +107.1%Operating income−0.05Net income−0.05Fiscal year 2019Revenue0.11 −14.9%Operating income−0.18Net income−0.18EPS, diluted−0.85Fiscal year 2020Revenue0.48 +344.1%Operating income−0.08Net income0.02EPS, diluted0.06Fiscal year 2021Revenue18.98 +3,834.6%Operating income15.28Net income10.29 +67,613.8%EPS, diluted39.63 +65,950.0%Fiscal year 2022Revenue17.31 −8.8%Operating income12.64Net income9.43 −8.3%EPS, diluted37.77 −4.7%Fiscal year 2023Revenue3.82 −77.9%Operating income0.69Net income0.93 −90.1%EPS, diluted3.83 −89.9%Fiscal year 2024Revenue2.75 −28.0%Operating income−1.31Net income−0.67 −171.5%EPS, diluted−2.77 −172.3%Fiscal year 2025Revenue2.87 +4.3%Operating income−1.40Net income−1.14EPS, diluted−4.70
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 0.06 0.13 0.11 0.48 18.98 17.31 3.82 2.75 2.87
Growth +107.1% −14.9% +344.1% +3,834.6% −8.8% −77.9% −28.0% +4.3%
Operating income −0.06 −0.05 −0.18 −0.08 15.28 12.64 0.69 −1.31 −1.40
Net income −0.09 −0.05 −0.18 0.02 10.29 9.43 0.93 −0.67 −1.14
Growth +67,613.8% −8.3% −90.1% −171.5%
EPS, diluted n/a n/a −0.85 0.06 39.63 37.77 3.83 −2.77 −4.70
Growth +65,950.0% −4.7% −89.9% −172.3%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2017Gross margin84.9%Operating margin−99.5%Net margin−139.1%Free cash flow margin−124.8%Fiscal year 2018Gross margin89.3%Operating margin−42.2%Net margin−37.6%Free cash flow margin−69.6%Fiscal year 2019Gross margin84.0%Operating margin−167.1%Net margin−164.9%Free cash flow margin−218.3%Fiscal year 2020Operating margin−17.1%Net margin3.2%Free cash flow margin−16.5%Fiscal year 2021Operating margin80.5%Net margin54.2%Free cash flow margin4.0%Fiscal year 2022Operating margin73.0%Net margin54.5%Free cash flow margin76.5%Fiscal year 2023Operating margin18.1%Net margin24.4%Free cash flow margin134.1%Fiscal year 2024Operating margin−47.8%Net margin−24.2%Free cash flow margin−2.9%Fiscal year 2025Operating margin−49.0%Net margin−39.6%Free cash flow margin9.8%
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin 84.9% 89.3% 84.0% n/a n/a n/a n/a n/a n/a
Operating margin −99.5% −42.2% −167.1% −17.1% 80.5% 73.0% 18.1% −47.8% −49.0%
Net margin −139.1% −37.6% −164.9% 3.2% 54.2% 54.5% 24.4% −24.2% −39.6%
Free cash flow margin −124.8% −69.6% −218.3% −16.5% 4.0% 76.5% 134.1% −2.9% 9.8%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2017Operating cash flow−0.05Capital expenditure−0.02Free cash flow−0.08Fiscal year 2018Operating cash flow−0.06Capital expenditure−0.03Free cash flow−0.09Fiscal year 2019Operating cash flow−0.20Capital expenditure−0.04Free cash flow−0.24Fiscal year 2020Operating cash flow−0.01Capital expenditure−0.07Free cash flow−0.08Dividends paid0.00Fiscal year 2021Operating cash flow0.89Capital expenditure−0.13Free cash flow0.76Dividends paid0.00Fiscal year 2022Operating cash flow13.58Capital expenditure−0.33Free cash flow13.25 +1,638.2%Dividends paid−0.48Fiscal year 2023Operating cash flow5.37Capital expenditure−0.25Free cash flow5.12 −61.3%Dividends paid0.00Fiscal year 2024Operating cash flow0.21Capital expenditure−0.29Free cash flow−0.08 −101.5%Dividends paid0.00Fiscal year 2025Operating cash flow0.46Capital expenditure−0.18Free cash flow0.28
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −0.05 −0.06 −0.20 −0.01 0.89 13.58 5.37 0.21 0.46
Capital expenditure −0.02 −0.03 −0.04 −0.07 −0.13 −0.33 −0.25 −0.29 −0.18
Free cash flow −0.08 −0.09 −0.24 −0.08 0.76 13.25 5.12 −0.08 0.28
Growth +1,638.2% −61.3% −101.5%
Dividends paid n/a n/a n/a 0.00 0.00 −0.48 0.00 0.00 n/a

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2017Cash0.17Shareholders’ equity−0.05Fiscal year 2018Cash0.41Shareholders’ equity0.27Fiscal year 2019Cash0.52Total debt0.07Net cash (debt)0.45Shareholders’ equity0.49Debt to equity0.14Fiscal year 2020Cash1.21Total debt0.23Net cash (debt)0.98Shareholders’ equity1.37Debt to equity0.17Fiscal year 2021Cash1.69Total debt0.17Net cash (debt)1.52Shareholders’ equity11.89Debt to equity0.01Fiscal year 2022Cash13.88Shareholders’ equity20.06Fiscal year 2023Cash11.66Shareholders’ equity20.25Fiscal year 2024Cash9.76Shareholders’ equity19.41Fiscal year 2025Cash7.68Shareholders’ equity19.22
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 0.17 0.41 0.52 1.21 1.69 13.88 11.66 9.76 7.68
Total debt n/a n/a 0.07 0.23 0.17 n/a n/a n/a n/a
Net cash (debt) n/a n/a 0.45 0.98 1.52 n/a n/a n/a n/a
Shareholders’ equity −0.05 0.27 0.49 1.37 11.89 20.06 20.25 19.41 19.22
Debt to equity n/a n/a 0.14 0.17 0.01 n/a n/a n/a n/a

In billions of EUR, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In billions of EUR, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
0.06 0.13 0.11 0.48 18.98 17.31 3.82 2.75 2.87
Growth +107.1% −14.9% +344.1% +3,834.6% −8.8% −77.9% −28.0% +4.3%
0.01 0.01 0.02 0.06 2.91 3.00 0.60 0.54 0.64
0.05 0.11 0.09 n/a n/a n/a n/a n/a n/a
Growth +117.8% −19.9%
0.09 0.14 0.23 0.65 0.95 1.54 1.78 2.25 2.10
0.02 0.03 0.05 0.09 0.28 0.48 0.50 0.53 0.51
−0.06 −0.05 −0.18 −0.08 15.28 12.64 0.69 −1.31 −1.40
Growth −17.3% −94.5% −290.4%
−0.09 −0.05 −0.18 −0.15 15.05 12.95 1.19 −0.68 −1.05
0.00 0.00 −0.00 −0.16 4.75 3.52 0.26 −0.01 0.09
−0.09 −0.05 −0.18 0.02 10.29 9.43 0.93 −0.67 −1.14
Growth +67,613.8% −8.3% −90.1% −171.5%
Per share
n/a n/a −0.85 0.06 42.18 38.78 3.87 −2.77 −4.70
n/a n/a −0.85 0.06 39.63 37.77 3.83 −2.77 −4.70
Growth +65,950.0% −4.7% −89.9% −172.3%
166.8 190.7 211.5 235.4 244.0 243.3 240.6 240.4 241.7
166.8 190.7 211.5 248.5 259.7 249.8 242.7 240.4 241.7
Growth +14.4% +10.9% +17.5% +4.5% −3.8% −2.8% −0.9% +0.5%

Shown in EUR as filed; the screener converts to dollars.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 42.9% a year over five years.
  • The diluted share count fell 2.7% in five years, so buybacks did some of the work per share.
  • Operating margin is down 31.9 points on five years ago, at -49.0%.
  • A net loss in 5 of 9 years on file.